| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |